Gansu Longshenrongfa Pharmaceutical Co., Ltd.

SZSE

Currency in CNY
11.18
-1.67 (-13.00%)

Closed

Jul 24, 2026

Day's Range

11.04
12.67

52 wk Range

6.78
14.00
Loading

Key Statistics

Symbol

300534

Name

Gansu Longshenrongfa Pharmaceutical Co., Ltd.

Currency

CNY

Exchange

SZSE

High

12.67000

Low

11.040000

Open

‪11.04‬

Last

‪11.18‬

Market Cap

3.39B

Pe Ratio

‪69.87‬

Volume

83.22M

Average Volume

90.39M

Dividend Yield

‪0.17%‬

Change

-1.67

Percent Change

-13.00

Timestamp

2026-07-24

Close

11.18000

Today Range Start

‪11.04‬

Today Range End

‪12.67‬

52 Week Range Start

‪6.78‬

52 Week Range End

‪14.00‬

Type

Stocks

Country

China

Historical Data - 300534 - Gansu Longshenrongfa Pharmaceutical Co., Ltd.

Historical Data

TimeOpenHighLowCloseVolume

No data available

Market Cap - 300534 - Gansu Longshenrongfa Pharmaceutical Co., Ltd.

Market Cap

2026-05-08

2.83B

2026-05-07

2.80B

2026-05-06

2.82B

2026-04-30

2.87B

2026-04-29

2.87B

2026-04-28

2.87B

2026-04-27

2.86B

2026-04-24

2.85B

2026-04-23

2.77B

2026-04-22

2.81B

Dividend - 300534 - Gansu Longshenrongfa Pharmaceutical Co., Ltd.

Dividend

2025-09-24

0.0200

Splits

2017-05-10

35-for-10 split (0.28571)

Splits - 300534 - Gansu Longshenrongfa Pharmaceutical Co., Ltd.

Earnings - 300534 - Gansu Longshenrongfa Pharmaceutical Co., Ltd.

Earnings

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-04-10--0.16-0.140.02‪-12.50%‬
2026-03-25--0.69-0.650.04‪-5.80%‬
2026-03-09--1.03-1.43-0.40‪+38.83%‬
2025-11-19-0.250.330.08‪+32.00%‬
2025-10-29-2.622.04-0.58‪-22.14%‬

Balance Sheet - 300534 - Gansu Longshenrongfa Pharmaceutical Co., Ltd.

Balance Sheet

Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
ExpandAssets
1.39B1.44B1.33B1.31B824.07M866.66M
ExpandLiabilities
613.42M705.47M625.14M434.21M91.23M127.52M
ExpandShareholders Equity
781.07M739.66M711.51M883.29M732.83M739.13M

Cash Flow - 300534 - Gansu Longshenrongfa Pharmaceutical Co., Ltd.

Cash Flow

Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
ExpandOperating Activities
------
ExpandInvesting Activities
------
ExpandFinancing Activities
------
End Cash Position241.03M310.02M288.69M369.24M99.12M118.18M
Income Tax Paid------
Interest Paid------
Free Cash Flow-49.89M137.23M-29.83M242.02M50.72M24.94M

Income Statement - 300534 - Gansu Longshenrongfa Pharmaceutical Co., Ltd.

Income Statement

Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Sales886.95M1.04B1.08B799.68M287.81M254.89M
Cost of Goods281.43M291.27M386.22M341.48M195.42M171.79M
Gross Profit605.52M751.22M693.82M458.19M92.39M83.10M
ExpandOperating Expense
------
Operating Income105.56M98.58M101.31M64.22M-5.14M4.85M
ExpandNon-Operating Interest
------
Other Income Expense------
Pre Tax Income81.14M101.75M97.01M66.14M-4.74M3.81M
Income Tax15.78M51.67M13.16M17.48M1.54M535.54K
Net Income65.36M50.08M83.85M48.65M-6.29M3.28M
EPS Basic-0.08070.20320.1279-0.030.006
EPS Diluted-0.08070.20320.1279-0.030.006
Basic Shares Outstanding-303.30M303.38M303.24M303.53M305.18M
Diluted Shares Outstanding-303.30M303.38M303.24M303.53M305.18M
Ebit83.80M104.87M100.96M66.14M-4.21M5.88M
Ebitda136.45M142.05M140.09M98.82M24.28M27.93M
Net Income Continuous Operations65.36M50.08M83.85M48.65M-6.29M3.28M
Minority Interests-21.41M-25.60M-22.20M-9.86M-2.80M-1.45M
Preferred Stock Dividends000000

Recommendations - 300534 - Gansu Longshenrongfa Pharmaceutical Co., Ltd.

Recommendations

DateStrong BuyBuyHoldSellStrong Sell
Jul 202600000
Jun 202600000
May 202600000
Apr 202600000

Profile - 300534 - Gansu Longshenrongfa Pharmaceutical Co., Ltd.

Profile

Mic Code

XSHE

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

641


Gansu Longshenrongfa Pharmaceutical Co., Ltd. is an established entity in the pharmaceutical sector, engaged primarily in the research, development, production, and distribution of herbal medicines. The company focuses on creating products that integrate traditional Chinese medicinal practices with modern healthcare needs, aiming to cater to a diverse clientele seeking alternative and complementary healthcare solutions. Gansu Longshenrongfa's portfolio includes a variety of herbal formulations and remedies, which are predominantly based on traditional Chinese medicine principles. These products are utilized in areas such as pain relief, enhanced immune function, and the overall maintenance of health and wellness. The company plays a significant role in the pharmaceutical market by bridging the gap between traditional and modern medicine, and it operates within regulatory frameworks that ensure the efficacy and safety of its products. Headquartered in Gansu Province, China, Gansu Longshenrongfa is positioned to leverage its heritage in traditional medicine, catering not only to domestic markets but also aiming to expand its influence globally in a growing industry that is witnessing increased demand for natural and holistic healthcare options.

Profile Details

Type

Common Stock

Address

No. 138, Jinke Road

City

Lanzhou

Zip

730102

Country

China

Phone

86 93 1214 3336

Related news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.
Gansu Longshenrongfa Pharmaceutical (300534 - SZSE) Price Today | UA Finance